DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

May 8, 2025

Study Completion Date

May 8, 2025

Conditions
Cardiac Surgery
Interventions
BIOLOGICAL

Human platelets

Platelets given to control bleeding

Trial Locations (16)

19001

Abington Memorial Hospital, Abington

19107

Thomas Jefferson Univ. Hospital, Philadelphia

20037

George Washington University, Washington D.C.

21201

University of Maryland Medical Center, Baltimore

21218

Johns Hopkins University, Baltimore

22042

Inova Cardiac Vascular, Falls Church

22908

University of Virginia Medical Center, Charlottesville

27710

Duke University Hospital, Durham

32608

UF Health, Gainesville

35205

University of Alabama, Birmingham

43210

The Ohio State Univ. Wexner Medical Center, Columbus

73104

OU Medical Center, Oklahoma City

80045

University of Colorado, Aurora

97239

Oregon Health and Science University, Portland

04102

Maine Medical Center, Portland

03756

Dartmouth Hitchcock Medical Center, Lebanon

Sponsors
All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

lead

Cellphire Therapeutics, Inc.

INDUSTRY